KYTX 8-K 2026-11-12

Kyverna Therapeutics, Inc. (KYTX) 8-K dated 2026-11-12 — accession 0001193125-26-457040.

Kyverna Therapeutics, Inc. (KYTX) is a biotechnology company listed on NASDAQ.

Kyverna Therapeutics, Inc. filed a 8-K on 2026-11-12. Accession 0001193125-26-457040.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for KYTX is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The KYTX SEC hub lists recent forms. The stock page is the research view.